Oncology Intelligence Digest June 05, 2026 Parabilis Medicines priced its Nasdaq IPO at $413M-$476M (base / with overallotment)…
Oncology Intelligence Membership Required
You must be a Oncology Intelligence member to access this content.
Already a member? Log in here